Back to Rare Disease
This trial is complete. It is no longer accepting participants.

NCT01304043

NCT01304043
Completed Not Applicable

Who may be able to join

Who might be able to join this trial:

  • You must be over 18 years old
  • You must have been diagnosed with a specific type of ovarian tumour (affecting the cells that produce eggs or hormones), confirmed by a tissue sample test
  • You may be starting your first treatment or being treated for a return of the condition
  • You must be willing and able to sign a consent form agreeing to take part in the study

Who may not be able to join:

  • You may not be able to join if you have a mental health condition or cognitive difficulty that would make it hard to understand what the study involves and follow its instructions (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Trial details

Status
Completed
Phase
Not Applicable
Sponsor
ARCAGY/ GINECO GROUP
Registry
clinicaltrials_gov
Start date
1 January 2002

Where this trial is recruiting

🇫🇷 France

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov